Biofield Corporation has developed a state of the art technology that will transform the way the world currently detects breast cancer. This technology, the Biofield Breast Cancer Proliferation Rate Detection System, or BDS, will make expensive, inaccessible, and less accurate mammograms and other breast cancer diagnostic technologies obsolete.

Early detection of breast cancer will be easier than ever before with BDS available to health professionals worldwide. BDS technology allows women to receive instant results without pain or discomfort like currently used breast cancer screening technology. In addition to its non-evasive and rapid diagnostic abilities, BDS is ten times less expensive than currently used screening technology. And unlike mammograms that use radiation to detect cancer, BDS uses no radiation therefore being completely safe with numerous testing being allowed without concerns to the patient’s health. BDS differentiates the different electrical waves given off by healthy and cancerous cells in a woman’s breast, and unlike mammograms, can tell a woman whether a lump in her breast is benign or malignant within 10-15 minutes and most importantly without biopsy, surgery or any invasive procedure, radiation or compression-all factors which discourage women worldwide from seeking early detection until it is unfortunately too late.

BDS is intended to first supplement, but eventually replace costly mammograms, which women in more developing countries currently cannot afford. BDS is more accurate than mammograms, which are plagued by false positives and thus unnecessary biopsies, and can detect smaller legions, which a mammogram cannot. BDS is approximately the size of a laptop computer and can be transported to more remote areas and can be administered by a nurse or trained technician, rather than a physician and a radiologist who are both required to administer a mammogram.

BDS will raise breast cancer awareness, promote early detection and help save millions of lives, especially in more developing countries that have up to now suffered due to women not being able to afford traditional mammograms or are unable to travel to a hospital or medical center that is capable of testing at all.